Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News State Street SPDR S&P Biotech ETF XBI

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value... see more

Opinion & Analysis (ARCA:XBI)

Let volatility power your micro-cap biotechs

The Life Sciences Report April 28, 2016

Breaking Down Biotech ETFs With Leverage

Benzinga.com  October 2, 2015

ETF Outlook: More Biotech Blunders Or A Biotech Bounce?

Benzinga.com  September 27, 2015

Traders Bet Against Hillary With Leveraged Biotech ETF

Benzinga.com  September 23, 2015

Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet

Benzinga.com  September 22, 2015

A Bad Sign For Biotech Bulls

Benzinga.com  August 20, 2015

Bullboard Posts (ARCA:XBI)

CEO Nick Kadysh - Pharmala Biotech Interview

For investors interested in the psychedelics sector of biotech.  Pharmala Biotech the #1 supplier of GMP MDMA for clinical trials...
inviolablspirit - April 8, 2025

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
GwenTracy - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
GwenTracy - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
GwenTracy - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
GwenTracy - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

GwenTracy - May 11, 2022